Search

Jared Barsky

Examiner (ID: 7259, Phone: (571)272-2795 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1628
Total Applications
1117
Issued Applications
492
Pending Applications
146
Abandoned Applications
503

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10676499 [patent_doc_number] => 20160022644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility' [patent_app_type] => utility [patent_app_number] => 14/799311 [patent_app_country] => US [patent_app_date] => 2015-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4252 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14799311 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/799311
Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility Jul 13, 2015 Abandoned
Array ( [id] => 10663609 [patent_doc_number] => 20160009753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'Reducing Risk of Contracting Clostridium-Difficile Associated Disease' [patent_app_type] => utility [patent_app_number] => 14/798276 [patent_app_country] => US [patent_app_date] => 2015-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17599 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798276 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/798276
Reducing risk of contracting clostridium-difficile associated disease Jul 12, 2015 Issued
Array ( [id] => 16138969 [patent_doc_number] => 10702538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Ship inhibition to induce activation of natural killer cells [patent_app_type] => utility [patent_app_number] => 15/319326 [patent_app_country] => US [patent_app_date] => 2015-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 14506 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319326 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/319326
Ship inhibition to induce activation of natural killer cells Jun 16, 2015 Issued
Array ( [id] => 10365759 [patent_doc_number] => 20150250764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3HIMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES' [patent_app_type] => utility [patent_app_number] => 14/722949 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4233 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14722949 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/722949
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3HIMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES May 26, 2015 Abandoned
Array ( [id] => 17921520 [patent_doc_number] => 11464741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Spray dried compositions having different dissolution profiles and processes for their preparation [patent_app_type] => utility [patent_app_number] => 14/722541 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8578 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14722541 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/722541
Spray dried compositions having different dissolution profiles and processes for their preparation May 26, 2015 Issued
Array ( [id] => 10457949 [patent_doc_number] => 20150342963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES' [patent_app_type] => utility [patent_app_number] => 14/719933 [patent_app_country] => US [patent_app_date] => 2015-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26372 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14719933 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/719933
Natural combination hormone replacement formulations and therapies May 21, 2015 Issued
Array ( [id] => 10354876 [patent_doc_number] => 20150239882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'NOVEL MONOHYDRATE OF AZAADAMANTANE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/707681 [patent_app_country] => US [patent_app_date] => 2015-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18809 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707681 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/707681
NOVEL MONOHYDRATE OF AZAADAMANTANE DERIVATIVES May 7, 2015 Abandoned
Array ( [id] => 11713540 [patent_doc_number] => 20170182040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'EPITHELIAL ION CHANNEL (ENAC) BLOCKERS TO TREAT PSORIASIS' [patent_app_type] => utility [patent_app_number] => 15/304999 [patent_app_country] => US [patent_app_date] => 2015-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11919 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304999 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/304999
EPITHELIAL ION CHANNEL (ENAC) BLOCKERS TO TREAT PSORIASIS Apr 30, 2015 Abandoned
Array ( [id] => 17058938 [patent_doc_number] => 11103520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-31 [patent_title] => Analogs of N-acetlyglucosamine and uses thereof [patent_app_type] => utility [patent_app_number] => 15/305609 [patent_app_country] => US [patent_app_date] => 2015-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16889 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305609 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/305609
Analogs of N-acetlyglucosamine and uses thereof Apr 22, 2015 Issued
Array ( [id] => 11689510 [patent_doc_number] => 20170165226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-15 [patent_title] => 'COMPOSITION COMPRISING AN ESTER OF ALPHA-TOCOPHEROL FOR PREVENTION AND TREATMENT OF ALLERGIC RHINITIS' [patent_app_type] => utility [patent_app_number] => 15/325890 [patent_app_country] => US [patent_app_date] => 2015-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1676 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325890 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/325890
COMPOSITION COMPRISING AN ESTER OF ALPHA-TOCOPHEROL FOR PREVENTION AND TREATMENT OF ALLERGIC RHINITIS Apr 16, 2015 Abandoned
Array ( [id] => 10676543 [patent_doc_number] => 20160022688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'NOVEL USE FOR IMIDAZOTRIAZINONES' [patent_app_type] => utility [patent_app_number] => 14/681513 [patent_app_country] => US [patent_app_date] => 2015-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10317 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14681513 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/681513
NOVEL USE FOR IMIDAZOTRIAZINONES Apr 7, 2015 Abandoned
Array ( [id] => 10387882 [patent_doc_number] => 20150272889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'Orally Disintegrating Tablet' [patent_app_type] => utility [patent_app_number] => 14/679447 [patent_app_country] => US [patent_app_date] => 2015-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4007 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14679447 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/679447
Orally Disintegrating Tablet Apr 5, 2015 Abandoned
Array ( [id] => 12183930 [patent_doc_number] => 20180042867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'METHODS OF TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 15/556155 [patent_app_country] => US [patent_app_date] => 2015-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11765 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556155 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/556155
METHODS OF TREATING CANCER Mar 31, 2015 Abandoned
Array ( [id] => 11895175 [patent_doc_number] => 09765100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Nucleoside phosphonate salts' [patent_app_type] => utility [patent_app_number] => 14/672816 [patent_app_country] => US [patent_app_date] => 2015-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11254 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14672816 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/672816
Nucleoside phosphonate salts Mar 29, 2015 Issued
Array ( [id] => 10346150 [patent_doc_number] => 20150231155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'ONAPRISTONE POLYMORPHIC FORMS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/661382 [patent_app_country] => US [patent_app_date] => 2015-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4409 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14661382 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/661382
ONAPRISTONE POLYMORPHIC FORMS AND METHODS OF USE Mar 17, 2015 Abandoned
Array ( [id] => 12283111 [patent_doc_number] => 09931350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Anti-infective and osteogenic compositions and methods of use [patent_app_type] => utility [patent_app_number] => 14/645040 [patent_app_country] => US [patent_app_date] => 2015-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 15786 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645040 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/645040
Anti-infective and osteogenic compositions and methods of use Mar 10, 2015 Issued
Array ( [id] => 10987486 [patent_doc_number] => 20160184431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID' [patent_app_type] => utility [patent_app_number] => 14/645297 [patent_app_country] => US [patent_app_date] => 2015-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10711 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645297 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/645297
TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID Mar 10, 2015 Abandoned
Array ( [id] => 10373113 [patent_doc_number] => 20150258119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'TOPICAL CORTICOSTEROID COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/645338 [patent_app_country] => US [patent_app_date] => 2015-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12308 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645338 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/645338
TOPICAL CORTICOSTEROID COMPOSITIONS Mar 10, 2015 Abandoned
Array ( [id] => 10289144 [patent_doc_number] => 20150174142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS' [patent_app_type] => utility [patent_app_number] => 14/642096 [patent_app_country] => US [patent_app_date] => 2015-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5044 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14642096 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/642096
MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS Mar 8, 2015 Abandoned
Array ( [id] => 11393895 [patent_doc_number] => 20170014430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-19 [patent_title] => 'Cycloartenol-Containing Composition' [patent_app_type] => utility [patent_app_number] => 15/124556 [patent_app_country] => US [patent_app_date] => 2015-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8312 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15124556 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/124556
Cycloartenol-Containing Composition Mar 5, 2015 Abandoned
Menu